Autoantibodies to CTLA-4 enhance T cell proliferation.
Matsui
T
T
Nishioka
K
K
Kato
T
T
Yamamoto
K
K
D000069594:Abatacept; D019138:Antibodies, Blocking / Q000276:immunology; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000276:immunology*; D000945:Antigens, Differentiation, T-Lymphocyte; D001172:Arthritis, Rheumatoid / Q000276:immunology; D001323:Autoantibodies / Q000494:pharmacology*; D001528:Behcet Syndrome / Q000276:immunology; D060908:CTLA-4 Antigen; D002455:Cell Division; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000276:immunology*; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects*; D007959:Lymphocyte Culture Test, Mixed; D013601:T-Lymphocytes / Q000187:drug effects / Q000502:physiology*
D019138:Antibodies, Blocking; D015703:Antigens, CD; D000943:Antigens, Differentiation; D000945:Antigens, Differentiation, T-Lymphocyte; D001323:Autoantibodies; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept